Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 83451-83500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05504278
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
PHASE1
Recruiting
144 participants
Started: Sep 20, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05461313
Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip
NA
Recruiting
146 participants
Started: Sep 20, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT05145595
Pain Sensitivity During Puberty
NA
Active, not recruiting
200 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT05409066
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
PHASE3
Active, not recruiting
549 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2029
1 condition
2 sponsors
273 locations
NCT06699524
Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid
N/A
Active, not recruiting
122 participants
Started: Sep 20, 2022 · Completed: Dec 20, 2024
1 condition
1 sponsor
1 location
NCT06272799
Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.
N/A
Recruiting
160 participants
Started: Sep 20, 2022 · Completed: Sep 20, 2024
1 condition
1 sponsor
1 location
NCT05564949
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
NA
Recruiting
15 participants
Started: Sep 20, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
2 locations
NCT06073938
Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement
N/A
Recruiting
30 participants
Started: Sep 20, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05507112
TIME in Immunotherapy Combined With nCRT for Rectal Cancer
PHASE2
Not yet recruiting
100 participants
Started: Sep 20, 2022 · Completed: Dec 1, 2029
1 condition
1 sponsor
0 locations
NCT05048212
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
PHASE2
Recruiting
20 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05260177
Study on the Effect of 40 Hz Non-Invasive Light Therapy System
NA
Recruiting
62 participants
Started: Sep 20, 2022 · Completed: Dec 1, 2026
1 condition
5 sponsors
1 location
NCT05409989
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
NA
Active, not recruiting
154 participants
Started: Sep 20, 2022 · Completed: Nov 30, 2029
1 condition
1 sponsor
25 locations
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE3
Recruiting
810 participants
Started: Sep 20, 2022 · Completed: Nov 30, 2033
1 condition
1 sponsor
266 locations
NCT05202080
Effect of a Pre-operative Internet-based Educational Video on Post Operative Opioid Consumption
NA
Recruiting
220 participants
Started: Sep 20, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05515770
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
PHASE3
Recruiting
1,200 participants
Started: Sep 20, 2022 · Completed: Feb 28, 2026
1 condition
5 sponsors
1 location
NCT05073224
Muscle Function After Childbirth
NA
Recruiting
78 participants
Started: Sep 20, 2022 · Completed: Sep 30, 2024
5 conditions
1 sponsor
2 locations
NCT05437380
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
NA
Recruiting
70 participants
Started: Sep 20, 2022 · Completed: Jun 28, 2026
2 conditions
1 sponsor
1 location
NCT05401968
Osteoporosis Patient Education in Denmark
NA
Active, not recruiting
3,132 participants
Started: Sep 19, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05583942
A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
NA
Recruiting
10 participants
Started: Sep 19, 2022 · Completed: Aug 1, 2025
3 conditions
2 sponsors
2 locations
NCT05462717
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
PHASE1
Active, not recruiting
222 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
64 locations
NCT04758975
Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
PHASE2
Recruiting
55 participants
Started: Sep 19, 2022 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT05280379
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
N/A
Active, not recruiting
60 participants
Started: Sep 19, 2022 · Completed: Dec 7, 2025
2 conditions
1 sponsor
1 location
NCT05363631
Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab
PHASE1/PHASE2
Recruiting
55 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT05309421
A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma
PHASE2
Active, not recruiting
17 participants
Started: Sep 19, 2022 · Completed: Mar 30, 2026
2 conditions
2 sponsors
4 locations
NCT05574361
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
NA
Recruiting
120 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT05362994
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
NA
Recruiting
54 participants
Started: Sep 19, 2022 · Completed: Feb 28, 2025
3 conditions
2 sponsors
1 location
NCT05391295
Mapping Emotional Dynamics During Corticosteroid Treatment
N/A
Recruiting
12 participants
Started: Sep 19, 2022 · Completed: Mar 31, 2025
2 conditions
1 sponsor
1 location
NCT05285358
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
PHASE1
Recruiting
12 participants
Started: Sep 19, 2022 · Completed: Oct 11, 2028
8 conditions
2 sponsors
1 location
NCT05172245
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
PHASE1
Recruiting
46 participants
Started: Sep 19, 2022 · Completed: Jun 1, 2026
26 conditions
1 sponsor
18 locations
NCT05530694
Rheumatoid Arthritis Shared Decision Making
NA
Recruiting
792 participants
Started: Sep 19, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
4 locations
NCT05492448
Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease
NA
Recruiting
120 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05358535
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
PHASE3
Recruiting
200 participants
Started: Sep 19, 2022 · Completed: Mar 31, 2026
6 conditions
1 sponsor
1 location
NCT05521048
Doxycycline in Cutaneous Schwannoma (NF2)
PHASE1/PHASE2
Recruiting
19 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06222801
The 1st Tumor CytokinoTherapy Database (TCTD-1)
N/A
Recruiting
5,000 participants
Started: Sep 19, 2022 · Completed: Dec 1, 2032
1 condition
1 sponsor
1 location
NCT05456503
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620
PHASE3
Recruiting
72 participants
Started: Sep 19, 2022 · Completed: Aug 31, 2028
3 conditions
2 sponsors
1 location
NCT04887337
Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode
NA
Recruiting
30 participants
Started: Sep 19, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT05680597
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
NA
Recruiting
80 participants
Started: Sep 19, 2022 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT05559164
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
PHASE2
Recruiting
60 participants
Started: Sep 19, 2022 · Completed: Mar 1, 2027
2 conditions
1 sponsor
10 locations
NCT05538416
"Short-term Clinical Outcome of Cortical Bone Trajectory Compared With the Traditional Open and Minimal Invasive Posterior Lumbar Interbody Fusion"
N/A
Recruiting
180 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT07145502
Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes
N/A
Active, not recruiting
76 participants
Started: Sep 19, 2022 · Completed: Sep 19, 2027
3 conditions
1 sponsor
1 location
NCT05553652
The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
NA
Recruiting
720 participants
Started: Sep 19, 2022 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT06171204
The Use of Stromal Vascular Fraction for Knee Arthrosis
NA
Recruiting
10 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06093633
A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
N/A
Recruiting
600 participants
Started: Sep 19, 2022 · Completed: Oct 1, 2025
1 condition
1 sponsor
3 locations
NCT05582928
Effects of EEG- Microstate Neurofeedback on Attention and Impulsivity in Adult Attention-deficit/Hyperactivity Disorder (ADHD) and Neurotypical Controls
NA
Recruiting
60 participants
Started: Sep 19, 2022 · Completed: Jun 30, 2025
2 conditions
3 sponsors
1 location
NCT05242484
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE2
Active, not recruiting
577 participants
Started: Sep 19, 2022 · Completed: Mar 27, 2029
1 condition
1 sponsor
403 locations
NCT05510739
Support for Physical Activity in Everyday Life With Parkinson's Disease
NA
Active, not recruiting
140 participants
Started: Sep 19, 2022 · Completed: Jul 31, 2025
4 conditions
2 sponsors
1 location
NCT05206097
Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol
NA
Active, not recruiting
87 participants
Started: Sep 19, 2022 · Completed: Dec 20, 2024
1 condition
1 sponsor
6 locations
NCT05377047
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NA
Recruiting
345 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2027
2 conditions
17 sponsors
1 location
NCT05450653
Trial of FETO for Severe Congenital Diaphragmatic Hernia
NA
Recruiting
10 participants
Started: Sep 18, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT05549635
Database and Biobank of Patients With Hypersensitivity Pneumonitis
N/A
Recruiting
50 participants
Started: Sep 18, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
Previous
1
More pages
1667
1668
1669
1670
1671
1672
1673
More pages
2369
Next